What top creators are saying about Victoria's Secret & Co.(VSCO)

Rallied hard following the return of its fashion show.

Stock has doubled as a downstream consumer beneficiary of GLP-1 weight-loss drug adoption driving demand for wardrobe resizing.

Emerging as an unexpected secondary beneficiary of the GLP-1 boom as widespread weight loss triggers a significant wardrobe and foundational garment replacement cycle.

Stock popped 40% on bets that a skinnier population due to GLP-1 drugs will spend more on apparel.

Surged 40% on earnings beat and a strategic branding turnaround; potentially benefiting from GLP-1 drug trends.

Turnaround play benefiting from GLP-1 weight-loss drug wardrobe refreshes and a return to traditional marketing.

Faces significant reputational risk due to its association with founder Les Wexner. His upcoming testimony regarding the Epstein scandal is likely to generate negative headlines and could harm consumer perception of the brand.

Faces significant reputational and headline risk due to its former CEO's deep connection to the Jeffrey Epstein case, posing a severe long-term risk to the stock and a major red flag for ESG investors.

The company faces significant reputational and headline risk as its founder, Les Wexner, is strongly linked to the brand and was mentioned in a congressional hearing regarding the Jeffrey Epstein case. This poses a major ESG risk and could cause stock price volatility.

As a brand formerly under L Brands, it may face negative impacts on its reputation and financial performance due to founder Leslie Wexner's association with the Epstein files.

A deep, problematic historical relationship between the former leader and Jeffrey Epstein creates significant legacy and reputational risk, along with governance concerns.

Reported strong earnings that beat expectations by 54%, which challenges the narrative that the consumer is weak and indicates resilience in the retail sector.

Reported strong earnings beats, supporting the positive trend in the retail market.